{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:27:20Z","timestamp":1791419240111,"version":"4.3.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T00:00:00Z","timestamp":1692489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T00:00:00Z","timestamp":1692489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00105-023-05207-5","type":"journal-article","created":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T22:01:38Z","timestamp":1692568898000},"page":"670-677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Praktischer Umgang mit Pruritus im Alter","Management of pruritus in the elderly"],"prefix":"10.1007","volume":"74","author":[{"given":"F.","family":"Witte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zeidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"St\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,20]]},"reference":[{"key":"5207_CR1","doi-asserted-by":"publisher","unstructured":"Agarwal P, Garg V, Karagaiah P et al (2021) Chronic kidney disease-associated pruritus. Toxins (Basel) 13(8):527. https:\/\/doi.org\/10.3390\/toxins13080527","DOI":"10.3390\/toxins13080527"},{"issue":"Suppl 4","key":"5207_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ddg.13580","volume":"16","author":"M Augustin","year":"2018","unstructured":"Augustin\u00a0M, Wilsmann-Theis\u00a0D, K\u00f6rber\u00a0A et al (2018) Positionspapier: Diagnostik und Therapie der Xerosis cutis. J\u00a0Dtsch Dermatol Ges 16(Suppl 4):3\u201335","journal-title":"J Dtsch Dermatol Ges"},{"key":"5207_CR3","first-page":"826","volume":"18","author":"F Bellinato","year":"2020","unstructured":"Bellinato\u00a0F, Maurelli\u00a0M, Gisondi\u00a0P et\u00a0al (2020) Klinische Merkmale und Behandlungen der transitorischen akantholytischen Dermatose (Morbus Grover): ein systematischer Review. J\u00a0Dtsch Dermatol Ges 18:826\u2013834","journal-title":"J Dtsch Dermatol Ges"},{"key":"5207_CR4","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s00105-004-0802-8","volume":"55","author":"A Brune","year":"2004","unstructured":"Brune\u00a0A, Metze\u00a0D, Luger\u00a0TA et al (2004) Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients. Hautarzt 55:1130\u20131136","journal-title":"Hautarzt"},{"key":"5207_CR5","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1152\/physrev.00017.2019","volume":"100","author":"F Cevikbas","year":"2020","unstructured":"Cevikbas\u00a0F, Lerner\u00a0EA (2020) Physiology and Pathophysiology of Itch. Physiol Rev 100:945\u2013982","journal-title":"Physiol Rev"},{"key":"5207_CR6","doi-asserted-by":"crossref","first-page":"569287","DOI":"10.3389\/fimmu.2021.569287","volume":"12","author":"D Didona","year":"2021","unstructured":"Didona\u00a0D, Scarsella\u00a0L, Fehresti\u00a0M et\u00a0al (2021) Autoreactive peripheral blood T helper cell responses in bullous pemphigoid and elderly patients with pruritic disorders. Front Immunol 12:569287","journal-title":"Front Immunol"},{"key":"5207_CR7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10354-021-00903-0","volume":"172","author":"P Dovjak","year":"2022","unstructured":"Dovjak\u00a0P (2022) Polypharmacy in elderly people. Wien Med Wochenschr 172:109\u2013113","journal-title":"Wien Med Wochenschr"},{"key":"5207_CR8","doi-asserted-by":"crossref","first-page":"521.e1","DOI":"10.1016\/j.jaad.2012.10.063","volume":"68","author":"JO Endo","year":"2013","unstructured":"Endo\u00a0JO, Wong\u00a0JW, Norman\u00a0RA et\u00a0al (2013) Geriatric dermatology: Part I. Geriatric pharmacology for the dermatologist. J\u00a0Am Acad Dermatol 68:521.e1\u2013521.e10","journal-title":"J Am Acad Dermatol"},{"key":"5207_CR9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1912770","volume":"382","author":"S Fishbane","year":"2020","unstructured":"Fishbane\u00a0S, Jamal\u00a0A, Munera\u00a0C et\u00a0al (2020) A phase\u00a03 trial of difelikefalin in hemodialysis patients with pruritus. N\u00a0Engl J Med 382:222\u2013232","journal-title":"N Engl J Med"},{"key":"5207_CR10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/jdv.18221","volume":"36","author":"M Gael","year":"2022","unstructured":"Gael\u00a0M, Adam\u00a0T, Mariano-Bourin\u00a0M et al (2022) Efficacy of dupilumab in chronic prurigo and chronic idiopathic pruritus: a\u00a0systematic review of current evidence and analysis of response predictors. J\u00a0Eur Acad Dermatol Venereol 36:1541\u20131551","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5207_CR11","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/jid.2013.446","volume":"134","author":"RJ Hay","year":"2014","unstructured":"Hay\u00a0RJ, Johns\u00a0NE, Williams\u00a0HC et\u00a0al (2014) The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J\u00a0Invest Dermatol 134:1527\u20131534","journal-title":"J Invest Dermatol"},{"key":"5207_CR12","first-page":"1475","volume":"139","author":"A Ikoma","year":"2003","unstructured":"Ikoma\u00a0A, Rukwied\u00a0R, St\u00e4nder\u00a0S et\u00a0al (2003) Neurophysiology of pruritus: interaction of itch and pain. Arch Dermatol 139:1475\u20131478","journal-title":"Arch Dermatol"},{"key":"5207_CR13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-4632.2011.05311.x","volume":"51","author":"M Jafferany","year":"2012","unstructured":"Jafferany\u00a0M, Huynh\u00a0TV, Silverman\u00a0MA et\u00a0al (2012) Geriatric dermatoses: a\u00a0clinical review of skin diseases in an aging population. Int J Dermatol 51:509\u2013522","journal-title":"Int J Dermatol"},{"key":"5207_CR14","doi-asserted-by":"publisher","unstructured":"Kim JC, Shim WS, Kwak IS et\u00a0al (2023) Pathogenesis and treatment of pruritus associated with chronic kidney disease and cholestasis. Int J Mol Sci 24(2):1559. https:\/\/doi.org\/10.3390\/ijms24021559","DOI":"10.3390\/ijms24021559"},{"key":"5207_CR15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00105-013-2700-4","volume":"65","author":"K Maleki","year":"2014","unstructured":"Maleki\u00a0K, Weisshaar\u00a0E (2014) Drug-induced pruritus. Hautarzt 65:436\u2013442","journal-title":"Hautarzt"},{"key":"5207_CR16","first-page":"627","volume":"113","author":"D Mo\u00dfhammer","year":"2016","unstructured":"Mo\u00dfhammer\u00a0D, Haumann\u00a0H, M\u00f6rike\u00a0K et\u00a0al (2016) Polypharmacy\u2014An upward trend with unpredictable effects. Dtsch \u00c4rztebl Int 113:627\u2013633","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"5207_CR17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2332\/allergolint.10-OA-0182","volume":"59","author":"H Murota","year":"2010","unstructured":"Murota\u00a0H, Kitaba\u00a0S, Tani\u00a0M et al (2010) Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases. Allergol Int 59:345\u2013354","journal-title":"Allergol Int"},{"key":"5207_CR18","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/sj.ki.5000251","volume":"69","author":"I Narita","year":"2006","unstructured":"Narita\u00a0I, Alchi\u00a0B, Omori\u00a0K et\u00a0al (2006) Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int 69:1626\u20131632","journal-title":"Kidney Int"},{"key":"5207_CR19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.abd.2021.06.007","volume":"97","author":"TR Nietsche","year":"2022","unstructured":"Nietsche\u00a0TR, Dotta\u00a0G, Barcaui\u00a0CB et\u00a0al (2022) Cholestatic pruritus: a\u00a0knowledge update. An Bras Dermatol 97:332\u2013337","journal-title":"An Bras Dermatol"},{"key":"5207_CR20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0190-9622(96)90715-X","volume":"35","author":"JM Parsons","year":"1996","unstructured":"Parsons\u00a0JM (1996) Transient acantholytic dermatosis (Grover\u2019s disease): a\u00a0global perspective. J\u00a0Am Acad Dermatol 35:653\u2013666 (quiz 667\u2013670)","journal-title":"J Am Acad Dermatol"},{"key":"5207_CR21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1590\/1980-5497201700020013","volume":"20","author":"KG Pereira","year":"2017","unstructured":"Pereira\u00a0KG, Peres\u00a0MA, Iop\u00a0D et al (2017) Polypharmacy among the elderly: a\u00a0population-based study. Rev Bras Epidemiol 20:335\u2013344","journal-title":"Rev Bras Epidemiol"},{"key":"5207_CR22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.alit.2016.08.009","volume":"66","author":"MP Pereira","year":"2017","unstructured":"Pereira\u00a0MP, St\u00e4nder\u00a0S (2017) Assessment of severity and burden of pruritus. Allergol Int 66:3\u20137","journal-title":"Allergol Int"},{"key":"5207_CR23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11899-016-0353-y","volume":"11","author":"A Phan","year":"2016","unstructured":"Phan\u00a0A, Veldman\u00a0R, Lechowicz\u00a0MJ (2016) T\u2011cell lymphoma epidemiology: the known and unknown. Curr Hematol Malig Rep 11:492\u2013503","journal-title":"Curr Hematol Malig Rep"},{"key":"5207_CR24","volume-title":"Jahresbericht 2016 des Datenanalysten zur Qualit\u00e4t in der Dialyse nach QSD-RL","author":"FMC Potthoff","year":"2017","unstructured":"Potthoff\u00a0FMC, Berendes\u00a0A, Weber\u00a0W (2017) Jahresbericht 2016 des Datenanalysten zur Qualit\u00e4t in der Dialyse nach QSD-RL"},{"key":"5207_CR25","volume-title":"StatPearls","author":"BA Robbins","year":"2023","unstructured":"Robbins\u00a0BA, Schmieder\u00a0GJ (2023) Brachioradial pruritus. In: StatPearls. StatPearls, Treasure Island"},{"key":"5207_CR26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ejp.760","volume":"20","author":"B Rowe","year":"2016","unstructured":"Rowe\u00a0B, Yosipovitch\u00a0G (2016) Malignancy-associated pruritus. Eur J Pain 20:19\u201323","journal-title":"Eur J Pain"},{"key":"5207_CR27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.clindermatol.2018.05.007","volume":"36","author":"R Sacotte","year":"2018","unstructured":"Sacotte\u00a0R, Silverberg\u00a0JI (2018) Epidemiology of adult atopic dermatitis. Clin Dermatol 36:595\u2013605","journal-title":"Clin Dermatol"},{"key":"5207_CR28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1365-2230.2006.02211.x","volume":"31","author":"G Schneider","year":"2006","unstructured":"Schneider\u00a0G, Driesch\u00a0G, Heuft\u00a0G et\u00a0al (2006) Psychosomatic cofactors and psychiatric comorbidity in patients with chronic itch. Clin Exp Dermatol 31:762\u2013767","journal-title":"Clin Exp Dermatol"},{"key":"5207_CR29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.clindermatol.2017.10.005","volume":"36","author":"A Shevchenko","year":"2018","unstructured":"Shevchenko\u00a0A, Valdes-Rodriguez\u00a0R, Yosipovitch\u00a0G (2018) Causes, pathophysiology, and treatment of pruritus in the mature patient. Clin Dermatol 36:140\u2013151","journal-title":"Clin Dermatol"},{"key":"5207_CR30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/cts.13173","volume":"15","author":"MJ Shram","year":"2022","unstructured":"Shram\u00a0MJ, Spencer\u00a0RH, Qian\u00a0J et al (2022) Evaluation of the abuse potential of difelikefalin, a\u00a0selective kappa-opioid receptor agonist, in recreational polydrug users. Clin Transl Sci 15:535\u2013547","journal-title":"Clin Transl Sci"},{"key":"5207_CR31","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jaad.2020.02.060","volume":"82","author":"JI Silverberg","year":"2020","unstructured":"Silverberg\u00a0JI, Yosipovitch\u00a0G, Simpson\u00a0EL et\u00a0al (2020) Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase\u00a03\u00a0studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS. J\u00a0Am Acad Dermatol 82:1328\u20131336","journal-title":"J Am Acad Dermatol"},{"key":"5207_CR32","doi-asserted-by":"crossref","first-page":"108078","DOI":"10.1016\/j.diabres.2020.108078","volume":"162","author":"A Sinclair","year":"2020","unstructured":"Sinclair\u00a0A, Saeedi\u00a0P, Kaundal\u00a0A et al (2020) Diabetes and global ageing among 65\u201399-year-old adults: Findings from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract 162:108078","journal-title":"Diabetes Res Clin Pract"},{"key":"5207_CR33","doi-asserted-by":"crossref","first-page":"101826","DOI":"10.1016\/j.eclinm.2023.101826","volume":"57","author":"H Sofen","year":"2023","unstructured":"Sofen\u00a0H, Bissonnette\u00a0R, Yosipovitch\u00a0G et al (2023) Efficacy and safety of vixarelimab, a\u00a0human monoclonal oncostatin M receptor \u03b2 antibody, in moderate-to-severe prurigo nodularis: a\u00a0randomised, double-blind, placebo-controlled, phase 2a study. EClinicalMedicine 57:101826","journal-title":"EClinicalMedicine"},{"key":"5207_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000446009","volume":"50","author":"S St\u00e4nder","year":"2016","unstructured":"St\u00e4nder\u00a0S (2016) Classification of Itch. Curr Probl Dermatol 50:1\u20134","journal-title":"Curr Probl Dermatol"},{"key":"5207_CR35","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/exd.13953","volume":"28","author":"S St\u00e4nder","year":"2019","unstructured":"St\u00e4nder\u00a0S (2019) How to define chronic pruritus: Symptom or disease? Exp Dermatol 28:1461\u20131465","journal-title":"Exp Dermatol"},{"key":"5207_CR36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000319862","volume":"221","author":"S St\u00e4nder","year":"2010","unstructured":"St\u00e4nder\u00a0S, Sch\u00e4fer\u00a0I, Phan\u00a0NQ et al (2010) Prevalence of chronic pruritus in Germany: results of a\u00a0cross-sectional study in a\u00a0sample working population of 11,730. Dermatology (Basel) 221:229\u2013235","journal-title":"Dermatology (Basel)"},{"key":"5207_CR37","doi-asserted-by":"crossref","first-page":"e10968","DOI":"10.1371\/journal.pone.0010968","volume":"5","author":"S St\u00e4nder","year":"2010","unstructured":"St\u00e4nder\u00a0S, Siepmann\u00a0D, Herrgott\u00a0I et\u00a0al (2010) Targeting the neurokinin receptor 1 with aprepitant: a\u00a0novel antipruritic strategy. PLoS One 5:e10968","journal-title":"PLoS One"},{"key":"5207_CR38","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJMoa1908316","volume":"382","author":"S St\u00e4nder","year":"2020","unstructured":"St\u00e4nder\u00a0S, Yosipovitch\u00a0G, Legat\u00a0FJ et al (2020) Trial of nemolizumab in moderate-to-severe prurigo nodularis. N\u00a0Engl J Med 382:706\u2013716","journal-title":"N Engl J Med"},{"key":"5207_CR39","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/ddg.14830_g","volume":"20","author":"S St\u00e4nder","year":"2022","unstructured":"St\u00e4nder\u00a0S, Zeidler\u00a0C, Augustin\u00a0M et\u00a0al (2022) S2k Leitlinie: Diagnostik und Therapie des chronischen Pruritus. J\u00a0Dtsch Dermatol Ges 20:1386\u20131402","journal-title":"J Dtsch Dermatol Ges"},{"key":"5207_CR40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00002512-200118030-00002","volume":"18","author":"HH Tan","year":"2001","unstructured":"Tan\u00a0HH, Goh\u00a0CL (2001) Parasitic skin infections in the elderly: recognition and drug treatment. Drugs Aging 18:165\u2013176","journal-title":"Drugs Aging"},{"key":"5207_CR41","doi-asserted-by":"crossref","first-page":"100512","DOI":"10.1016\/j.xkme.2022.100512","volume":"4","author":"J Topf","year":"2022","unstructured":"Topf\u00a0J, Wooldridge\u00a0T, Mccafferty\u00a0K et al (2022) Efficacy of difelikefalin for the treatment of moderate to severe Pruritus in hemodialysis patients: pooled analysis of KALM\u20111 and KALM-2\u00a0phase\u00a03 studies. Kidney Med 4:100512","journal-title":"Kidney Med"},{"key":"5207_CR42","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2340\/00015555-1968","volume":"95","author":"R Valdes-Rodriguez","year":"2015","unstructured":"Valdes-Rodriguez\u00a0R, Mollanazar\u00a0NK, Gonz\u00e1lez-Muro\u00a0J et al (2015) Itch prevalence and characteristics in a\u00a0Hispanic geriatric population: a\u00a0comprehensive study using a\u00a0standardized itch questionnaire. Acta Derm Venereol 95:417\u2013421","journal-title":"Acta Derm Venereol"},{"key":"5207_CR43","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/jdv.17816","volume":"36","author":"E Weisshaar","year":"2022","unstructured":"Weisshaar\u00a0E, Szepietowski\u00a0JC, Bernhard\u00a0JD et al (2022) Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a\u00a0phase\u00a02 randomized controlled trial with an open-label extension phase. J\u00a0Eur Acad Dermatol Venereol 36:453\u2013461","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5207_CR44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2340\/00015555-1959","volume":"95","author":"E Weisshaar","year":"2015","unstructured":"Weisshaar\u00a0E, Weiss\u00a0M, Mettang\u00a0T et\u00a0al (2015) Paraneoplastic itch: an expert position statement from the Special Interest Group (SIG) of the International Forum on the Study of Itch (IFSI). Acta Derm Venereol 95:261\u2013265","journal-title":"Acta Derm Venereol"},{"key":"5207_CR45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2337\/dc09-0632","volume":"33","author":"H Yamaoka","year":"2010","unstructured":"Yamaoka\u00a0H, Sasaki\u00a0H, Yamasaki\u00a0H et\u00a0al (2010) Truncal pruritus of unknown origin may be a\u00a0symptom of diabetic polyneuropathy. Diabetes Care 33:150\u2013155","journal-title":"Diabetes Care"},{"key":"5207_CR46","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jaci.2018.09.005","volume":"142","author":"G Yosipovitch","year":"2018","unstructured":"Yosipovitch\u00a0G, Rosen\u00a0JD, Hashimoto\u00a0T (2018) Itch: From mechanism to (novel) therapeutic approaches. J\u00a0Allergy Clin Immunol 142:1375\u20131390","journal-title":"J Allergy Clin Immunol"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05207-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-023-05207-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05207-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T14:04:07Z","timestamp":1693922647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-023-05207-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,20]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["5207"],"URL":"https:\/\/doi.org\/10.1007\/s00105-023-05207-5","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,20]]},"assertion":[{"value":"18 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0Witte gibt an, dass kein Interessenkonflikt besteht. C.\u00a0Zeidler gibt an, dass folgende Interessenkonflikte bestehen: Durchf\u00fchrung klinischer Studien: Novartis, Janssen, Pfizer, UCB, Lilly, AbbVie, Boehringer Ingelheim, Sanofi, Regeneron, Leo, Galderma; Vortragst\u00e4tigkeit: Dermasence, Beiersdorf, Leo, Sanofi, Novartis, Unna Akademie; Beratung: Sanofi, Almirall; Autorenschaft: AbbVie. S.\u00a0St\u00e4nder gibt an, dass folgende Interessenkonflikte bestehen: Beratung, Advisory Board: AbbVie, Almirall, Beiersdorf, Bellus Health, Benevolent, Bionorica, Cara, Clexio, DS Biopharma, Eli Lilly, Galderma, Integrity CE, Kiniksa, Klinge Pharma, Leo Pharma, Pfizer, Sanofi, TouchIMe, Trevi, Vifor, WebMD; Sprecherin: Almirall, BMS, Eli Lilly, Sanofi, Galderma, L\u2019Or\u00e9al, Omnicuris, Beiersdorf, Leo Pharma, Novartis, Unna Akademie, Pfizer, UCB, Vifor; Forschungsstipendien: Almirall, Deutsche Forschungsgesellschaft (DFG), European Academy of Dermatology and Venereology (EADV), Leo Pharma, Novartis, Sanofi, Trevi Therapeutics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}